ANDERSON ELIZABETH M
SEC Form 4 insider trading activity
ANDERSON ELIZABETH M has filed 7 SEC Form 4 filings (13 transaction rows) across 3 companies, including RVMD, BMRN, INSM, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Sep 24, 2026.
On the most recent filing, ANDERSON ELIZABETH M is listed as Director at Revolution Medicines, Inc. Inside the rolling window, ANDERSON ELIZABETH M reported no open-market purchases and 3 open-market sales totaling $4.9M in RVMD and INSM. The largest disclosed transaction in the window is a sale of 10,000 INSM shares on Nov 14, 2025, worth $2.0M.
Companies traded
Other insiders at RVMD
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.9M
reported sales (SEC code S)
Companies
3
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has ANDERSON ELIZABETH M made?
ANDERSON ELIZABETH M has filed 7 SEC Form 4 filings (13 transaction rows) across 3 companies, including RVMD, BMRN, INSM since 2025.
Which companies does ANDERSON ELIZABETH M trade?
ANDERSON ELIZABETH M has filed SEC Form 4 disclosures for 3 companies, including RVMD, BMRN, INSM.
When was ANDERSON ELIZABETH M's most recent SEC Form 4 filing?
ANDERSON ELIZABETH M's most recent SEC Form 4 filing on Tracefour is dated Sep 24, 2026.
What is ANDERSON ELIZABETH M's total buy and sell value in the current window?
Inside the rolling retention window, ANDERSON ELIZABETH M bought $0 and sold $4.9M based on SEC Form 4 filings.
What was ANDERSON ELIZABETH M's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,000 INSM shares on 2025-11-14, worth $2.0M, per SEC Form 4 filings.